These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35306171)

  • 21. Equine immunoglobulin F(ab')
    Zhao Y; Zheng X; He S; Li Y; Wang W; Gai W; Wong G; Wang H; Yan F; Xue F; Feng N; Wang T; Gao Y; Yang S; Qiu X; Xia X
    Int Immunopharmacol; 2018 Nov; 64():217-222. PubMed ID: 30199846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross clade prophylactic and therapeutic efficacy of polyvalent equine immunoglobulin F(ab')2 against highly pathogenic avian influenza H5N1 in mice.
    Zhao Z; Yan F; Chen Z; Luo D; Duan Y; Yang P; Li Z; Peng D; Liu X; Wang X
    Int Immunopharmacol; 2011 Dec; 11(12):2000-6. PubMed ID: 21906698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Equine Anti-SARS-CoV-2 Serum (ECIG) Binds to Mutated RBDs and N Proteins of Variants of Concern and Inhibits the Binding of RBDs to ACE-2 Receptor.
    Andrade SA; Batalha-Carvalho JV; Curi R; Wen FH; Covas DT; Chudzinski-Tavassi AM; Moro AM
    Front Immunol; 2022; 13():871874. PubMed ID: 35898497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-SARS-CoV-2 Immunoglobulin Isotypes, and Neutralization Activity Against Viral Variants, According to BNT162b2-Vaccination and Infection History.
    Tarkowski M; de Jager W; Schiuma M; Covizzi A; Lai A; Gabrieli A; Corbellino M; Bergna A; Ventura CD; Galli M; Riva A; Antinori S
    Front Immunol; 2021; 12():793191. PubMed ID: 34975897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased Antibody Avidity and Cross-Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Variants by Hyperimmunized Transchromosomic Bovine-Derived Human Immunoglobulins for Treatment of Coronavirus Disease 2019.
    Tang J; Grubbs G; Lee Y; Wu H; Luke TC; Egland KA; Bausch CL; Sullivan EJ; Khurana S
    J Infect Dis; 2022 Sep; 226(4):655-663. PubMed ID: 35106573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of Fc fragment of monoclonal antibodies to tetanus toxin neutralization.
    Ghotloo S; Amiri MM; Khoshnoodi J; Abbasi E; Jeddi-Tehrani M; Golsaz-Shirazi F; Shokri F
    Neurotox Res; 2020 Mar; 37(3):578-586. PubMed ID: 31721050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants.
    Choi A; Koch M; Wu K; Dixon G; Oestreicher J; Legault H; Stewart-Jones GBE; Colpitts T; Pajon R; Bennett H; Carfi A; Edwards DK
    J Virol; 2021 Nov; 95(23):e0131321. PubMed ID: 34549975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutralizing F(ab')2 fragments of protective monoclonal antibodies to yellow fever virus (YF) envelope protein fail to protect mice against lethal YF encephalitis.
    Schlesinger JJ; Chapman S
    J Gen Virol; 1995 Jan; 76 ( Pt 1)():217-20. PubMed ID: 7844536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
    Shi J; Zheng J; Tai W; Verma AK; Zhang X; Geng Q; Wang G; Guan X; Malisheni MM; Odle AE; Zhang W; Li F; Perlman S; Du L
    J Virol; 2022 Sep; 96(17):e0011822. PubMed ID: 35972290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, Beta, Delta, and Omicron variants.
    Banerjee A; Lew J; Kroeker A; Baid K; Aftanas P; Nirmalarajah K; Maguire F; Kozak R; McDonald R; Lang A; Gerdts V; Straus SE; Gilbert L; Li AX; Mozafarihashjin M; Walmsley S; Gingras AC; Wrana JL; Mazzulli T; Colwill K; McGeer AJ; Mubareka S; Falzarano D
    Med; 2022 Jun; 3(6):422-432.e3. PubMed ID: 35437520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics in rabbits and anti-sphingomyelinase D neutralizing power of Fab, F(ab')(2), IgG and IgG(T) fragments from hyper immune equine plasma.
    Vázquez H; Olvera F; Paniagua-Solís J; Alagón A; Sevcik C
    Int Immunopharmacol; 2010 Apr; 10(4):447-54. PubMed ID: 20093203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. History repeats itself: horse originated hyperimmune sera production against SARS CoV-2.
    Pakdemirli A; Çalışkan E; Hacıoğlu S; Danyer E; Kardoğan Ö; Kurt ZE; Yıldırım Ö; Taşkaya H; Ündar B; Sezgin Y; Ergin G; Ekici H; Ülker U; Taçbaş E; Çakır Ş; Bülbül R; Bebek M; Sarper M; Dülger D; Sarı ÜS; Ergin F; Kabaklı Ö; Yaralı C
    Turk J Med Sci; 2021 Oct; 51(5):2263-2273. PubMed ID: 34092050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunotherapy with anti-SARS-COV-2 neutralizing F(ab')2 antibodies from equine serum in the treatment of outpatients with bilateral COVID-19 pneumonia].
    Manganiello CF; Basbus L; Callegari MS; Cayol F; Amaral De Sousa CR; Porta RE;
    Medicina (B Aires); 2022; 82(5):667-672. PubMed ID: 36220022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection from infection with severe acute respiratory syndrome coronavirus in a Chinese hamster model by equine neutralizing F(ab')2.
    Luo D; Ni B; Zhao G; Jia Z; Zhou L; Pacal M; Zhang L; Zhang S; Xing L; Lin Z; Wang L; Li J; Liang Y; Shi X; Zhao T; Zou L; Wu Y; Wang X
    Viral Immunol; 2007 Sep; 20(3):495-502. PubMed ID: 17931120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of neutralizing antibodies against Omicron, Gamma and Delta SARS-CoV-2 variants following CoronaVac vaccination.
    Silva ARD; Villas-Boas LS; Tozetto-Mendoza TR; Honorato L; Paula A; Witkin SS; Mendes-Correa MC
    Rev Inst Med Trop Sao Paulo; 2022; 64():e19. PubMed ID: 35239863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine.
    Melo-González F; Soto JA; González LA; Fernández J; Duarte LF; Schultz BM; Gálvez NMS; Pacheco GA; Ríos M; Vázquez Y; Rivera-Pérez D; Moreno-Tapia D; Iturriaga C; Vallejos OP; Berríos-Rojas RV; Hoppe-Elsholz G; Urzúa M; Bruneau N; Fasce RA; Mora J; Grifoni A; Sette A; Weiskopf D; Zeng G; Meng W; González-Aramundiz JV; González PA; Abarca K; Ramírez E; Kalergis AM; Bueno SM
    Front Immunol; 2021; 12():747830. PubMed ID: 34858404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Severe Acute Respiratory Syndrome Coronavirus 2 Strain Variation on Virus Neutralization Titers: Therapeutic Use of Convalescent Plasma.
    Nguyen D; Xiao J; Simmonds P; Lamikanra A; Odon V; Ratcliff J; Townsend A; Roberts DJ; Harvala H
    J Infect Dis; 2022 Mar; 225(6):971-976. PubMed ID: 34751775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants.
    Moriyama S; Adachi Y; Sato T; Tonouchi K; Sun L; Fukushi S; Yamada S; Kinoshita H; Nojima K; Kanno T; Tobiume M; Ishijima K; Kuroda Y; Park ES; Onodera T; Matsumura T; Takano T; Terahara K; Isogawa M; Nishiyama A; Kawana-Tachikawa A; Shinkai M; Tachikawa N; Nakamura S; Okai T; Okuma K; Matano T; Fujimoto T; Maeda K; Ohnishi M; Wakita T; Suzuki T; Takahashi Y
    Immunity; 2021 Aug; 54(8):1841-1852.e4. PubMed ID: 34246326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Refinement of an ovine-based immunoglobulin therapy against SARS-CoV-2, with comparison of whole IgG versus F(ab')
    Findlay-Wilson S; Easterbrook L; Smith S; Pope N; Aldridge M; Humphries G; Schuhmann H; Ngabo D; Rayner E; Otter A; Coleman T; Hicks B; Halkerston R; Apostolakis K; Taylor S; Fotheringham S; Horton A; CanoCejas I; Wand M; Tree JA; Sutton M; Graham V; Hewson R; Dowall S
    Sci Rep; 2023 Aug; 13(1):13912. PubMed ID: 37626085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isotyping and quantitation of the humoral immune response to SARS-CoV-2.
    Goyins KA; Yu JJ; Papp SB; Beddard R; Murthy AK; Chambers JP; Arulanandam BP
    Exp Biol Med (Maywood); 2022 Jun; 247(12):1055-1060. PubMed ID: 35369776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.